Cite

HARVARD Citation

    Mitchell, P. et al. (2019). A drug safety review of treating eosinophilic asthma with monoclonal antibodies. Expert opinion on drug safety. 18 (12), pp. 1161-1170. [Online]. 
  
Back to record